Molecular reference standards

BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting

Retrieved on: 
Monday, November 13, 2023

BostonGene , a leading provider of AI-driven molecular and immune profiling solutions today announced that an abstract has been accepted as a poster presentation for the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, which will be held November 14 - 18, 2023, at the Salt Palace Convention Center in Salt Lake City, UT.

Key Points: 
  • BostonGene , a leading provider of AI-driven molecular and immune profiling solutions today announced that an abstract has been accepted as a poster presentation for the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, which will be held November 14 - 18, 2023, at the Salt Palace Convention Center in Salt Lake City, UT.
  • During the event, BostonGene will also deliver a presentation at the AMP Corporate Workshop day and exhibit at booth 1301.
  • Details of BostonGene’s presence at AMP are below:
    Speaker: Katerina Nuzhdina, R&D, Head of Bioinformatics Pipelines Clinical Integration Division, BostonGene
    Tumor molecular characterization is key for advancing precision oncology.
  • In collaboration with Agilent, BostonGene will present its method for detecting somatic variants from cancer samples, enabling large-scale data analyses.

ATCC Products to be Used in Microgravity Experiments on the International Space Station

Retrieved on: 
Friday, November 10, 2023

ATCC , the world’s premier biological materials management and standards organization, today announced that ATCC catalog item MSA-2003-ISS was sent to the International Space Station ( ISS National Lab ) on November 9th aboard the SpaceX CRS-29 Cargo Dragon Resupply Craft mission.

Key Points: 
  • ATCC , the world’s premier biological materials management and standards organization, today announced that ATCC catalog item MSA-2003-ISS was sent to the International Space Station ( ISS National Lab ) on November 9th aboard the SpaceX CRS-29 Cargo Dragon Resupply Craft mission.
  • “This is the first time that our products will be used in space to study microbial cells in microgravity,” said ATCC chairman and CEO Raymond H. Cypess , DVM, PhD.
  • It is a functioning research laboratory with the tools and facilities needed to translate traditional ground-based experiments into flight-ready payloads.
  • MSA-2003-ISS will be used in the uTitan DNA extraction payload studies to demonstrate extraction efficiency in zero gravity.

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Retrieved on: 
Wednesday, December 6, 2023

PALO ALTO, Calif., Dec. 6, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that its Palo Alto quality control testing facility has been accredited as ISO 17025: 2017 compliant. The accreditation was certified by ANSI National Accreditation Board, one of the leading accreditation bodies in the world. The tests in the scope of accreditation center on the characterization of iPSCs and include cell count and viability per USP , detection of pluripotency marker expression by flow cytometry per USP , and also by immunofluorescence assay. I Peace has also been accredited for a quantitative real-time PCR method to detect residual Sendai virus vectors in the reprogrammed cells. The current ISO accreditation at the I Peace Palo Alto facility shows that our quality control testing is carried out at a high standard. I Peace cell manufacturing facility in Kyoto, Japan has been certified as compliant with US FDA cGMP 21 CFR 211 and 1271, and ICH Q7, and licensed by the Japanese government to manufacture specific cell products, suggesting that its quality management system meets the industry's highest standards both in manufacturing and quality control testing of the manufactured cell products.

Key Points: 
  • The accreditation was certified by ANSI National Accreditation Board, one of the leading accreditation bodies in the world.
  • The current ISO accreditation at the I Peace Palo Alto facility shows that our quality control testing is carried out at a high standard.
  • We support drug discovery and cell medicine development by providing our iPS cell and other cell products as high-quality cell products that meet PMDA and FDA standards to pharmaceutical companies and cell medicine development companies.
  • We aim for the earliest prevalence of regenerative medicine by establishing iPS cell banking services for individuals.

BTQ and Hon Hai Research Institute Team Up To Help Pioneer Post-Quantum Cryptography Standards

Retrieved on: 
Wednesday, November 29, 2023

BTQ Technologies Corp. announces that its wholly owned subsidiary, BTQ AG, has entered into a Research and Collaboration Agreement with Hon Hai Research Institute.

Key Points: 
  • BTQ Technologies Corp. announces that its wholly owned subsidiary, BTQ AG, has entered into a Research and Collaboration Agreement with Hon Hai Research Institute.
  • In response to the call for PQC standard solicitation by the U.S. National Institute of Standards and Technology (NIST), BTQ and Hon Hai Research Institute's collaborative report was co-published in July 2023, demonstrating their combined expertise and commitment to advancing post-quantum cryptography standards.
  • The collaboration between BTQ and Hon Hai Research Institute began two years ago and the efforts in PQC led to the submission of a milestone report under the Research Program to the US National Institute of Standards and Technology (NIST) on June 1, 2023.
  • The contribution of Hon Hai Research Institute represents the forward-thinking direction in the field of post-quantum cryptography, which is in line with the trend of international academic research.

Midwest Surgical Hospital selects Wolters Kluwer’s Simplifi+ suite

Retrieved on: 
Tuesday, October 24, 2023

Taking action to ensure compliance amid this transition, Midwest Surgical Hospital has selected Wolters Kluwer Health ’s Simplifi 797® technology, alongside the full Simplifi+® Pharmacy Compliance suite of solutions, to replace manual processes and support patient safety at its 25-bed ambulatory surgical center in Omaha, Nebraska.

Key Points: 
  • Taking action to ensure compliance amid this transition, Midwest Surgical Hospital has selected Wolters Kluwer Health ’s Simplifi 797® technology, alongside the full Simplifi+® Pharmacy Compliance suite of solutions, to replace manual processes and support patient safety at its 25-bed ambulatory surgical center in Omaha, Nebraska.
  • Prior to this shift, Midwest Surgical was utilizing paper-based records in its pharmacy for compounding documentation and medication inventory management across the facility.
  • By implementing the full suite of Simplifi+ Pharmacy Compliance solutions, including Simplifi 797, Simplifi+ MedTrays and Simplifi+ MedStorage, Midwest Surgical can proactively manage USP compliance, medication storage, and emergency cart medication inventory on one common platform.
  • With a lean pharmacy team, we’re always looking for ways to streamline our processes – and ultimately their workloads,” said Michael Labadie, PharmD, Director of Pharmacy at Midwest Surgical Hospital.

Visiopharm and Boston Cell Standards Announce Partnership to Develop Joint IHC Technology for Magnani-Taylor Regulatory Proposal

Retrieved on: 
Tuesday, August 15, 2023

“The higher proposed assay requirements will raise the quality of IHC testing to ensure accurate results, which will benefit pathologists, oncologists and, ultimately, patients,” said Dr. Steven Bogen, CEO, Boston Cell Standards. “However, aligning IHC laboratory testing globally requires that labs have access to enabling quality assurance tools that, until recently, were not available -- calibration standards and image analysis quantification software to measure the calibrator test results.”

Key Points: 
  • Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine.
  • If adopted, the proposal would represent a significant shift in the IHC lab regulatory landscape, requiring labs to incorporate rigorous assay control methods and calibration.
  • Modern clinical laboratory quality assurance protocols include reference standards, assay calibration, quantitative controls, and standardized units of measure.
  • Visiopharm developed Qualitopix™, a groundbreaking AI-driven image analysis software for IHC assay control quantification and tracking (Levey-Jennings analysis).

Test and Measurement Equipment Market worth $42.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, May 26, 2023

Calibration services sub-segment in service type segment is expected to hold the highest market share of the test and measurement equipment market during the forecast period.

Key Points: 
  • Calibration services sub-segment in service type segment is expected to hold the highest market share of the test and measurement equipment market during the forecast period.
  • Calibration is the process of evaluating and adjusting the precision and accuracy of measurement equipment.
  • The calibration of the test and measurement equipment is vital to ensure precision, quality assurance, and compliance with quality standards during the production, maintenance, and servicing phases.
  • Industrial vertical is expected to account for the highest market share of the test and measurement equipment market during the forecast period.

Test and Measurement Equipment Market worth $42.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, May 26, 2023

Calibration services sub-segment in service type segment is expected to hold the highest market share of the test and measurement equipment market during the forecast period.

Key Points: 
  • Calibration services sub-segment in service type segment is expected to hold the highest market share of the test and measurement equipment market during the forecast period.
  • Calibration is the process of evaluating and adjusting the precision and accuracy of measurement equipment.
  • The calibration of the test and measurement equipment is vital to ensure precision, quality assurance, and compliance with quality standards during the production, maintenance, and servicing phases.
  • Industrial vertical is expected to account for the highest market share of the test and measurement equipment market during the forecast period.

Philips showcases its latest portfolio of cardiology innovations that deliver clinical confidence and efficiency in treating cardiac disease at EuroPCR 2023

Retrieved on: 
Thursday, May 11, 2023

The Philips cardiology portfolio addresses the need for integrating imaging, devices, software, informatics, and services at each point in the cardiac patient journey.

Key Points: 
  • The Philips cardiology portfolio addresses the need for integrating imaging, devices, software, informatics, and services at each point in the cardiac patient journey.
  • Philips’ proven physiology technologies can enable interventionalists to perform ultra-low contrast percutaneous coronary intervention (ULC-PCI) procedures with greater confidence.
  • In line with the company’s commitment to supporting its innovations with clinical evidence, Philips’ clinical partners will present new data during late-breaking sessions at EuroPCR that could help inform treatment for PCI patients.
  • For a full calendar of Philips events, session registration and to learn more about cardiology solutions being showcased in Philips Booth #F20 at EuroPCR 2023, please visit our website .

ATCC and USP Enter Strategic Collaboration to Support Global Quality Production of Biologics

Retrieved on: 
Thursday, February 23, 2023

Measurement of cellular DNA left over following purification is required by regulatory authorities to ensure product safety.

Key Points: 
  • Measurement of cellular DNA left over following purification is required by regulatory authorities to ensure product safety.
  • Two of the items support the most common platforms used in the rapidly growing cell and gene therapy sector.
  • USP and ATCC’s collaboration recognizes these challenges and combining the know-how of both organizations will empower better solutions.
  • “Healthcare and medicine are changing rapidly, and this agreement is just one example of the innovative ways that ATCC and USP are working to meet future needs.”